(3R,4S)-Tofacitinib
1092578-46-5
0.98%
Yes
2026-10-21
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName (3R,4S)-Tofacitinib Cat No CEI-1184 Product Overview Tasocitinib also known as CP690550 is an JAK kinase inhibitor. An IC50 estimated at 0.2 μM for PV patient progenitor cells. CAS No 1092578-46-5 Molecular Weight 312.37 Purity 0.98 Storage Store at-20°C Targets JAK Molecular Formula C16H20N6O Chemical Name 3-[(3R,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile Solubility Soluble in DMSO Shipping Conditions Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request category Specialty Chemicals(c26) cas_num 1092578-46-5 ECHEMI Editorial Reference(3r,4s)-Tofacitinib is a N-acylpiperidine.Basic Info-
Product Name:
3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
Other Name:3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile;(3R,4S)-Tofacitinib;RS-tofacitinib citirate;Tofacitinib IMpurity E;Tofacitinib Impurity A(3R,4S);(3R,4S)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile;Tofacitinib impurity 10/(3R,4S)-Tofacitinib/3-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino) piperidin-1-yl)-3-oxopropanenitrile;Tofacitinib Impurity A (3R,4S)-Tofacitinib
CAS No.:1092578-46-5
Molecular Formula:C16H20N6O
InChIKeys:UJLAWZDWDVHWOW-PZILLZCRNA-N
Molecular Weight:312.3696
Exact Mass:312.16985928
UNII:B64WR5WNB7
DSSTox ID:DTXSID40648965
Color/Form:Pale Yellow to Yellow
Categories:
Characteristics-
Density:
1.296
Melting Point:>108°C (dec.)
PKA:6.04±0.60(Predicted)
Critical Temperature & Pressure:Refrigerator
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
